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Endothelial dysfunction is recognized as a critical condition in the development of cardiovascular disorders. This multifactorial process
involves changes in the biochemical and mechanical properties of endothelial cells leading to disturbed release of vasoprotective mediators.
Hypercholesterolemia and increased stiffness of the endothelial cortex are independently shown to result in reduced release of nitric oxide
and thus endothelial dysfunction. However, direct evidence linking these parameters to each other is missing. Here, a novel method
combining Raman spectroscopy for biochemical analysis and Atomic Force Microscopy (AFM) for analyzing the endothelial nanomechanics
was established. Using this dual approach, the same areas of native ex vivo aortas were investigated, either derived from mice with
endothelial dysfunction (ApoE/LDLR−/−) or wild type mice. In particular an increased intracellular lipid content and elevated cortical
stiffness/elasticity were shown in ApoE/LDLR−/− aortas, demonstrating a direct link between endothelial dysfunction, the biochemical
composition and the nanomechanical properties of endothelial cells.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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and vasoprotective activity. In contrast, a reduced NO bioavail-
ability is a hallmark for endothelial dysfunction1,2 and has thus
prognostic and therapeutic significance.3–5 Recently, two
important determinants and predictors for the development of
endothelial dysfunction have been identified: The persistence of
hyperlipidemia6 and an increase in the mechanical stiffness of
the endothelial cell cortex.7,8 Hyperlipidemia-induced endothe-
lial dysfunction is, among other mechanisms, induced by profuse
incorporation of cholesterol into the plasma membrane. This
might cause endothelial NO synthase (eNOS) uncoupling and
thus a dysbalance between ROS- (reactive oxygen species) and
NO-production. Consequently, the resulting oxidative stress
leads to a pro-inflammatory/pro-thrombotic phenotype, which in
turn contributes to the development of atherosclerotic plaques.-
6,9–11 On the other hand, there is a direct relationship between
the stiffness of the endothelial cell cortex, the layer 50-150 nm
underneath the plasma membrane, and the endothelial NO
release: A stiff cortex results in reduced release of NO,7,12 a
condition which has recently been described as the ‘stiff
endothelial cell syndrome’ (SECS).13 Although a direct link
between eNOS activity/vascular function and (i) hypercholes-
terolemia and (ii) endothelial nanomechanics was demonstrated,
the direct relationship between the two parameters remains
elusive. Hence, aim of the present study was to show a link
between vascular function/dysfunction, the state of lipids and the
cortical stiffness of endothelial cells, in that all parameters were
detected within the same murine ex vivo aorta preparation. For
that, vessels from ApoE/LDLR−/− mice were investigated. This
mouse model is characterized by a double-knockout of the
apolipoprotein E (ApoE) and the low-density lipoprotein
receptor (LDLR).14 The lack of these two key players in the
lipid metabolism leads to increased plasma cholesterol levels (i.e.
hypercholesterolemia) in the ApoE/LDLR−/− mice.15 As
mentioned earlier, hypercholesterolemia in general is known to
cause membrane cholesterol incorporation in endothelial cells.11
Based on this, we postulate an increased lipid content in the
ApoE/LDLR−/− endothelium. Since the phenotype of this
mouse model is further characterized by a reduced basal
endothelial NO production,15 the ApoE/LDLR−/− mice serve
as a reliable model to investigate the proposed link between
vascular function/dysfunction, the state of lipids and the cortical
stiffness of endothelial cells. We established an experimental
approach to investigate vascular preparations by combined
Raman spectroscopy and Atomic Force Microscopy (AFM).
This setup enables the simultaneous quantification of biochem-
ical (Raman spectroscopy) and nanomechanical properties
(AFM) of living endothelial cells within the same area of the
ex vivo aorta preparation (see Figure 1). Further, the phenotype
of endothelial dysfunction in the ApoE/LDLR−/− mice was
confirmed by immunohistochemical stainings on fixed aortic
cross-sections for three independent markers of endothelial
dysfunction as well as directly detected aortic NO production by
electron paramagnetic resonance (EPR). Applying these meth-
odological approaches, we were able to directly link the
phenotype of endothelial dysfunction with elevated endothelial
lipid contents and simultaneously increased cortical stiffness
within the ApoE/LDLR−/− endothelial cells.Methods
Ethical approval for animal studies
In the present work, all experiments with murine aorta
preparations were approved by the Ethics Local Committee of
Jagiellonian University (Krakow, Poland) and were compliant
with the Guide for the Care and Use of Laboratory Animals of
the National Academy of Sciences (NIH publication No. 85-23,
revised 1996).
Aorta preparation for combined Raman and AFM measure-
ments
ApoE/LDLR−/− mice and C57/BL/6J mice (WT) at the age
of 6 months were euthanized by an intraperitoneal injection
consisting of ketamine (100 mg per kg body weight; Vetoquinol
Biowet, Poland) and xylazine (10 mg per kg body weight¸ Sigma
Aldrich, Germany).
Raman imaging
The Raman spectrum shows the intensity of the inelastically
scattered light as a function of its frequency. In Raman imaging,
multiple Raman spectra are recorded point by point within a
chosen area of the sample. After analysis, chemical images that
show the distribution of the components within the sample, are
obtained. Raman imaging and AFM-measurements were per-
formed in fluid with a Confocal Raman Imaging system (WITec
alpha 300, Germany) using a 60× water immersion objective
(Nikon Fluor, NA = 1, Netherlands). A laser excitation wave-
length of 532 nm, a laser power of approximately 20 mW and an
integration time of 0.3 s per spectrum were used in all
measurements. Images were recorded with an edge length of
15 × 15 μm2 and 60 × 60 pixels, whereas the spectral resolution
was 3 cm−1. The same area of the sample was imaged in 2-3
focal planes after movement in z-direction, whereas the baseline
layer was chosen by maximizing the intensity of the oscilloscope
signal.
Identification of the endothelial surface with Raman spectro-
scopy
As the major goal of this study was to investigate the
biochemical composition of vascular endothelial cells from
isolated aortas, a protocol that provides spectroscopic informa-
tion exclusively from the endothelium and not from the
underlying components of the vessel was established. This is
of great importance, as the ex vivo preparations are not flat
samples, but vary in thickness and surface topography at
different regions of the tissue. As a consequence, the chemical
images obtained after analysis, partly reflect also deeper layers of
the vessel preparation (e.g. basal lamina or VSMCs) and/or
signals resulting from higher parts (e.g. fluid), which may
influence the statistical analysis and thus the results themselves.
This phenomenon is additionally enhanced by the vertical
resolution of the confocal setup, which is about 1 μm. To account
for the natural roughness of the studied samples, the following
procedure was applied: Firstly, the integral intensities of the
bands caused by the C-H stretching vibrations in all organic
compounds in the 2800-3100 cm−1 range were calculated, as
Figure 1. Simplified scheme of the combined Raman- and AFM-measurements. Within the same area of the ex vivo aorta preparation biochemical and
nanomechanical information is obtained subsequently. First, Raman spectroscopy was performed using a 60× water immersion objective and a laser excitation
wavelength of 532 nm. Subsequently, nanoindentation measurements were performed using the AFM.
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Then, the integral intensities of the bands in the 3100-3600 cm−1
range, which are characteristic for water, were calculated for
every single spectrum of the image, as the measurements were
performed in fluid. Comparing the integral intensities of both
bands enabled localization of the endothelial layer: if the Raman
signal was collected in a deeper layer of the vessel, the water
band disappeared and the ratio from the intensities of the bands
caused by organic compounds and by water was higher. In
contrast, if the signal was taken above the vessel, the amount of
the detected water increased. Taking this into account, only
spectra fulfilling the following condition were included into the
analysis:
0:2b X1=X2ð Þb0:5
where:
x1 intensity in the 2800-3100 cm−1 range (all organic
compounds)
x2 intensity in the 3100-3600 cm−1 range (water)
Hence, solely those areas within the images were considered,
in which the contribution of water was high enough and the
signal from the tissue was still clearly detectable. Consequently,
the number of spectra included into the analysis was different for
every measurement and varied between 100 and 1100.
Following these rules, exclusively the endothelial layer was
included into the analysis. An example of such calculations is
presented in Figure 2.Stiffness measurements
In order to detect the biochemical and mechanical properties
within the same aortic area of the ex vivo preparation, the
confocal Raman imaging system was used in combination with
an AFM (WITec alpha 300). As shown in Figure 1, for AFM the
following elements are fundamental: (i) a cantilever, which
serves as a soft spring (ii) a tip, which is mounted to the
cantilever (iii) a laser, which is focused on the cantilever and gets
reflected from its backside and (iv) a photodiode, which detects
the reflection of the laser. Through precise movements in z-
direction, the cantilever is stepwise lowered onto the sample.
Interaction between cantilever and cell (indentation) leads to
bending of the cantilever which can be detected by the
photodiode and transformed into so-called force distance curves
(FDCs). Soft triangular cantilevers with gold coated backs and a
polystyrene sphere with 10 μm diameter as a tip were used
(Novascan, USA) for all measurements.16 Since no vibrometer-
based information about the exact spring constant of the
cantilevers was available and the thermal spectrum from soft
cantilevers in liquid is known to be inaccurate,17 the nominal
spring constant of the cantilevers was used for the analysis
(0.03 N/m). However, to ensure comparability between groups
and minimize the influence of differences in material properties
of the cantilever (e.g. spring constant or small variations in
sphere size), the same cantilever was used for as many
experiments as possible. Finally, two cantilevers were used for
the complete study (each cantilever: three WT and three ApoE/
LDLR−/− preparations). A trigger threshold of 150 nm was
chosen based on previous publications, in which the nanome-
chanical properties of the endothelial cell cortex were
investigated.16 During experiments the aortic ex vivo patches
Figure 2. Identification of the endothelial surface with Raman spectroscopy. (A-D) Raman images were obtained by calculating the integral intensities of the
bands characteristic for (A) all organic compounds (2800-3100 cm−1) and (B) water (3100-3600 cm−1), whereas brighter colors characterize higher intensities.
(C) Identification of the endothelial surface by extracting solely those spectra from both images, which fulfill the following condition: 0.2 b (×1/×2) b0.5;
whereas ×1: intensity in the 2800-3100 cm−1 range (all organic compounds) and ×2: intensity in the 3100-3600 cm−1 range (water). (D) Typical spectrum for the
identified endothelial area with two bands between 2800 and 3100 cm−1 and 3100-3600 cm−1. The fingerprint is given in the insert.
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solution (composition in mM: NaCl 140, KCl 5, MgCl2 1, CaCl2
1, glucose 5, HEPES 10 (N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid), pH 7.4). Nanoindentation measurements
on in situ endothelial cells of ex vivo aortic explants were
performed as described elsewhere.18–22 For each condition, 20
single in situ endothelial cells of ex vivo aortic preparations
were randomly selected on the monitor (Figure S1, C) and
measurements of these cells consisting of six to eight force-
distance curves per cell were recorded (Figure S1, D).
Furthermore, the quality of the aortic samples was occasionally
verified by light microscopy and Phalloidin/DAPI staining. No
morphological difference and a regular and intact endothelial
monolayer were confirmed of the representative samples (Figure
S2, A + B). Depending on the way of analysis, the resultingFDCs contain different information about the mechanical
properties, i.e. the “stiffness” or the “elasticity” of the endothelial
cell cortex. We first analyzed the slope of the FDC, which gives
direct information about the force (in Newton), which is needed
to indent the cell for a given distance. Here, the force is defined
as cell “stiffness”: the stiffer the sample, the higher the deflection
of the cantilever for a given deformation, i.e. the steeper the
slope of the FDC.16,19 Further, the FDCs obtained within the
combined Raman/AFM setup were additionally fitted with the
hypothetical Linear Hertz model, which gives information about
the cortical “elasticity”, i.e. Young's Modulus (in Kilopascal;
kPa).23 In both cases, the contact point of the cantilever was
defined by performing a baseline fit. Starting from this point, the
first linear part of the FDC has been analyzed, which could
independently be shown to reflect the cell cortex.16,24,25 The
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Indentation Analysis Software (PUNIAS), either in the mode for
“nanoindentation” or “Linear Hertz Model” (stiffness or Young's
Modulus, respectively). See Figure S1 for two representative FDCs
with Hertzian fitting of the first linear part. Based on previous
publications comparing spherical and conical tips23, we applied the
Hertz model with the sphere and a Poisson ratio of 0.5 for the
analysis of the Young's Modulus. An additional converter was
written for FDCs obtained with the WITec Project 2.10 software.
Each data point shown in the results section represents the cortical
stiffness or Young's Modulus of one spot respectively (mean of
maximally six to eight values of each spot).
Immunohistochemical stainings
To further document the manifestation of endothelial
dysfunction in the ApoE/LDLR−/− mice, additional aortic ex
vivo preparations were prepared and immunohistochemically
stained for typical markers of endothelial dysfunction. For that,
optimal cutting temperature (OCT)-frozen rings from the
thoracic aorta of 6 month-old ApoE/LDLR−/− and WT mice
were cut into 10 μm-thick cross-sections using a Leica CM1920
automatic cryostat (Leica, Wetzlar, Germany). Subsequently, the
sections were placed on poly-L-lysine-covered SuperFrost™
microscopic slides (Menzel-Gläser, Braunschweig, Germany),
followed by an acetone fixation for 10 min. Aortic rings were
preincubated with 5% normal goat serum (Jackson Immuno
Research, Pennsylvania, US) and 2% dry milk in PBS, then
immunostained using rat-anti-mouse CD141 (BD Biosc., New
Jersey, US), rabbit-anti-mouse von-Willebrand-factor (vWF)
(Abcam, Cambridge, GB) or rat-anti-mouse VCAM-1 (Milli-
pore, Massachusetts, US) primary antibodies. As secondary
antibodies Cy3-conjugated goat-anti-rat or Cy3-conjugated goat-
anti-rabbit were used, respectively (Jackson Immuno Research,
Pennsylvania, US). Images were acquired using an AxioCam
HRm digital monochromatic camera and an AxioObserver.D1
inverted fluorescent microscope (Carl Zeiss, Oberkochen,
Germany) and stored as tiff files.
For confocal immunofluorescence staining of cortical F-Actin
see supplementary material.
Nitric oxide spin trapping and EPR detection
EPR spin strapping using colloidal Fe(DETC)2 has been
shown to provide reliable measurements of vascular NO
production, by forming a stable NO-Fe(DETC)2 spin adduct.
26
Freshly isolated thoracic aortas of ApoE/LDLR−/− and WT
mice at the age of 6 months were cleaned of adherent fat and
connective tissue, opened longitudinally, and placed in 24-well
plates each filled with 100 μl Krebs–Hepes buffer (pH 7.4,
composition in mM: NaCl 99; KCl 4.7; MgSO4 1.2; KH2PO4
1.03; CaCl2 2.5; NaHCO3 25; glucose 5.6; and Na-Hepes 20)
and preincubated for 30 min at 37 °C. The buffer was filtered
through a 0.2 μm paper syringe filter (Macherey-Nagel,
Germany) and deoxygenized by bubbling argon gas for at least
30 min. DETC (3.6 mg) and FeSO4 · 7H2O (2.25 mg) were
separately dissolved under argon gas bubbling in two 10 ml
volumes of ice-cold Krebs–Hepes buffer and kept under gas
flow on ice until used. DETC and FeSO4 · 7H2O solutions weremixed 1:1 (v/v) to obtain 250 μl Fe(DETC)2 colloid per well
(final concentration 285 μM) and immediately added to the
aortas in parallel with the calcium ionophore A23187 (final
concentration 1 μM) to stimulate the nitric oxide synthase (NOS)
and incubated at 37 °C for 90 min. After the incubation, each
aorta was removed from the buffer, drained on a piece of wipes
(Kimwipes, USA) and wet mass was measured. Next the aorta
was placed into the middle of a column of Krebs–Hepes buffer,
frozen in liquid nitrogen and stored at −80 °C until measured.
EPR spectra were obtained in a finger Dewar (Noxygen,
Germany) containing liquid nitrogen, using an X-band EPR
spectrometer (EMX Plus, Bruker, Germany), equipped with a
rectangular resonator cavity H102. Instrument settings were:
center-field (B0) 3276 G, sweep 115 G, microwave power
10 mW, modulation frequency 100 kHz, amplitude modulation
8 G, sweep time 60 s, and number of scans 4. Signals were
quantified by measuring the total amplitude of the NO-Fe
(DETC)2, as done previously,
27 and normalized to tissue weight.
Statistics
Raman integral intensities were calculated in OPUS 5, while
all other values were calculated using OriginPro. All data are
considered significant if P ≤ 0.05. After testing for normal
distribution, the two sample t-test or Tukey test (Raman), the
two sample t-test or Mann–Whitney test (AFM) or the
unpaired, one-tailed t-test (EPR) was performed. All values
are given as mean ± SEM. AFM-based results are shown in box
plots: mean (square), median (horizontal line), 25th and 75th
percentile (box), minimal and maximal values (lower and upper
line).Results
Increased lipid content in aortic endothelium of ApoE/LDLR−/
− mice
After identifying the endothelial surface, average spectra
were obtained for the selected endothelial areas. The spectra
were normalized in the range of 1500-200 cm−1 and then the
intensities of the chosen marker bands were analyzed to obtain
quantitative information about the biochemical compounds
within the endothelium. To extract the information displaying
the intracellular lipid content, Raman bands in the range between
3030 and 2800 cm−1 were analyzed. As already mentioned, this
high region of Raman spectra reflects the content of all organic
compounds in the vessel. Importantly, the broad band in that
region is a superposition of C-H-stretching vibrations from lipids
and proteins.28,29 However, the Raman scattering cross-section
for lipids in this region is considerably higher than for proteins.
Therefore, the Raman intensity in the 2800-3030 cm−1 range
was assigned predominantly to lipid contributions. Furthermore,
a band at 1454 cm−1 can be observed, which is mostly assigned
to the CH2 scissoring vibrations in lipids.
28 Hence, both bands
are reliable markers of lipids within the ex vivo samples. We
found that the C-H stretching vibrations band at 3030-
2800 cm−1 was significantly increased (+17%) in the endothe-
lium of ApoE/LDLR−/− compared to WT mice (Figure 3, A;
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0.42391, n = 7, N = 4) suggesting that the intracellular content
of lipids was increased in the aortic endothelium in ApoE/LDLR
−/−mice. The intensity of the second marker band at 1454 cm−1
was also increased (by about 13%) in the aortic endothelium of
ApoE/LDLR−/− mice; however, the difference was not
statistically significant.Increased cortical stiffness and increased Young's Modulus in
ApoE/LDLR−/− endothelial cells
The cortical stiffness of the ApoE/LDLR−/− and WT
endothelium was determined within the same aortic area as
used for Raman measurements. As depicted in Figure 3, B
endothelial cells from ApoE/LDLR−/− aortas showed a
significantly higher cortical stiffness compared to WT mice
(+16%) (WT: 1.19 ± 0.034 pN/nm, n = 69, N = 6; ApoE/LDLR
−/−: 1.38 ± 0.028 pN/nm, n = 69, N = 6), thus indicating for a
coexistence of elevated lipid content and increased stiffness in
ApoE/LDLR−/− endothelial cells. Importantly, the same result
was found using the MultiMode AFM setup (+6% cortical
stiffness in ApoE/LDLR−/−) (WT: 0.98 ± 0.021 pN/nm, n =
56, N = 3; ApoE/LDLR−/−: 1.04 ± 0.025 pN/nm, n = 57, N =
3; data not shown). We further analyzed the data obtained with
the combined Raman/AFM setup applying the “Linear Hertz
Model (sphere)”. As can be seen in Figure 3, C the elasticity, i.e.
Young's Modulus is significantly increased by +22% within the
ApoE/LDLR−/− endothelial cells (WT: 0.46 ± 0.023 kPa, n =
54, N = 6; ApoE/LDLR−/−: 0.56 ± 0.022 kPa, n = 50, N = 6),
a result which is in line with the increased cortical stiffness and
proves the disturbed nanomechanical properties in the aortic
endothelium of the ApoE/LDLR−/− mice.Figure 3. Increased lipid content and increased cortical stiffness in the ApoE/
LDLR−/− endothelial cells. (A) Intensities of the lipid marker band in the
3030-2800 cm−1 range are shown, as this band is characteristic mostly for
lipids. The intensity of this specific band is increased by 17% within the
ApoE/LDLR−/− endothelial cells compared to WT, indicating a higher
intracellular amount of lipids. (WT: 10.30 ± 0.53713, n = 9, N = 6; ApoE/
LDLR−/−: 12.05 ± 0.42391, n = 7, N = 4; P ≤ 0.05). (B) AFM nanoin-
dentation measurements revealed a significantly higher cortical stiffness in
the ApoE/LDLR−/− endothelial cells compared to WT (+16%; WT: 1.19 ±
0.034 pN/nm, n = 69, N = 6; ApoE/LDLR−/−: 1.38 ± 0.028 pN/nm, n =
69, N = 6; P ≤ 0.05). (C) Besides the cortical stiffness, as well the Young's
Modulus is 22% higher in the ApoE/LDLR−/− endothelial cells when
compared to WT (WT: 0.46 ± 0.023 kPa, n = 54, N = 6; ApoE/LDLR−/−:
0.56 ± 0.022 kPa, n = 50, N = 6).Altered expression of adhesion molecules and decreased
endothelial NO production in ApoE/LDLR−/− mice
In order to confirm that the altered biochemical and
nanomechanical properties within the ApoE/LDLR−/− endothe-
lial cells are correlated with typical markers for endothelial
dysfunction, EPR-based measurements of NO produced by
ApoE/LDLR−/− and WT aorta were performed. As the state of
endothelial dysfunction is associated with increased expression
levels of the vWF and VCAM-130–32 and with a downregulation
of the vasoprotective protein thrombomodulin (CD141),33 the
expression of all three parameters has been analyzed by
immunohistochemical stainings. In Figure 4, A representative
fluorescence images of elastic fibers (green), nuclei (blue) and
VCAM-1, vWF or CD141 (red), respectively are shown: The
qualitative expression of VCAM-1 and vWF was found to be
increased, while the expression of CD141 was clearly decreased
in the ApoE/LDLR−/− aorta as compared to WT preparations.
Further, EPR measurements revealed a significantly diminished
NO production (−39%) after stimulation with a calcium
ionophore (A23187) in ApoE/LDLR−/− aortas as compared
with those from WT mice (Figure 4, B; WT: 38885 ± 3887
arbitrary units, N = 8; ApoE/LDLR−/−: 27022 ± 4122 arbitrary
units, N = 8; P ≤ 0.05).Discussion
In the present work we demonstrate that the phenotype of
endothelial dysfunction is directly linked to increased intracel-
lular lipid contents and simultaneously elevated cortical stiffness
in the ApoE/LDLR−/− mouse model. These results were
obtained by developing a novel multimodal approach: The
Figure 4. Immunohistochemical and spectrosopic identification of markers
for endothelial dysfunction in the thoracic aorta taken from WT and ApoE/
LDLR−/− mice. (A) Representative images of immunohistochemical
staining showing an increased expression of VCAM-1 and vWF and a
decreased expression of thrombomodulin (CD141) in aortic cross-sections
from ApoE/LDLR−/− mice when compared to WT. Red fluorescence (Cy3):
VCAM-1, vWF or CD141, respectively; green autofluorescence: elastic
fibers; blue fluorescence: nuclei (Hoechst 33258). (B) Results of EPR
spectroscopy showing a significantly reduced NO secretion from ApoE/
LDLR−/− aortas stimulated with a calcium-ionophore when compared to
WT, indicating for the persistence of severe endothelial dysfunction (−39%;
WT: 38885 ± 3887 arbitrary units, N = 8; ApoE/LDLR−/−: 27022 ± 4122
arbitrary units, N = 8; P ≤ 0.05).
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intracellular biochemical content and (ii) the nanomechanical
properties of living murine endothelial cells derived from ex vivo
aorta preparations. Importantly, an analytical approach was
developed which enabled us to exclusively extract the Raman
spectra reflecting the endothelial layer, and not the underlying
components of the vessel. Since the AFM-based results reflectthe mechanical properties of the endothelial cell cortex, we thus
obtained detailed information related to the outer endothelial
layer of the aorta. So far, previous investigations of our group
highlighted biochemical analyses based on fixed vessel
preparations.34–38 Investigating non-fixed cells is of relevance
for translational studies, since with this approach different
cellular processes leading to endothelial dysfunction can be
studied ex vivo. First the intracellular lipid content of endothelial
cells from hypercholesterolemic ApoE/LDLR−/− mice15 was
quantified and compared to WT mice. In general, a state of
hypercholesterolemia causes increased cholesterol-contents in
the endothelial plasma membrane.11 This again might result in
alterations of the membrane's physical properties and important
signaling pathways within the endothelial cells.39 In the present
work we did not analyze the cholesterol content, since in contrast
to infrared spectroscopy, which can hardly be performed on live
cells,40 the specific cholesterol marker bands are generally weak
using Raman spectroscopy. However, we could show, that the
intracellular lipid content of the endothelial cells from ApoE/
LDLR−/− mice is significantly increased by +17% compared to
WT endothelium. This highlights, that the phenotype of
endothelial dysfunction in this mouse model is linked to a state
of hypercholesterolemia and also to an increased intracellular
lipid content. However, in the present work we did not find
differences in lipids' saturation in endothelium from ApoE/
LDLR−/− as compared to WT mice that constituted a major
finding in lipid droplets in liver from ApoE/LDLR−/− mice.41
Accordingly, rather an accumulation of lipids than their
saturation is a dominant feature in dysfunctional endothelium
in atherosclerosis. Interestingly, previous investigations of our
group revealed, that the lipid/protein ratio in fixed fragments of
aorta from animal models reflecting diabetes, hypertension,
cancer metastasis or atherosclerosis is specific for each of the
studied disorders.35,37,38 Although on the biochemical level in all
examples of the studied disorders endothelial dysfunction is
linked to impaired NO-dependent vascular function and
activation of pro-inflammatory and pro-thrombotic processes,
the ratio of lipid/protein may be specific for a given vascular
disease. In particular, in the case of the ApoE/LDLR−/− mouse
model a significant decrease in the lipid/protein ratio was found
recently.34 This finding highlights that, besides the intracellular
lipid content, the amount of proteins (characterized by the
Raman band for amid I) is also affected by atherosclerotic
development. However, the results of the present study were
obtained in fluid, a protocol which does not allow an analysis of
the amid I-based protein content (and thus of the lipid/protein
ratio), because the Raman amid I band overlaps with the band for
water. Importantly, in the light of an impaired NO production in
the ApoE/LDLR−/− aorta, our Raman spectroscopic-based
findings correlate to the observation that increased intracellular
lipids diminish eNOS activity for example by eNOS uncoupling.-
6,9,39 This is in agreement with an observed tendency to a
decrease in the Tyr/Phe ratio (approximately 24% decrease; ns.;
data not shown), which was previously shown to be an indirect
biomarker for NOS uncoupling by applying Raman
spectroscopy.34 To further confirm the phenotype of endothelial
dysfunction, EPR-based measurements and immunohistochem-
ical stainings were performed to characterize typical markers for
104 M. Maase et al / Nanomedicine: Nanotechnology, Biology, and Medicine 16 (2019) 97–105endothelial dysfunction within the ApoE/LDLR−/− aortas: EPR-
measurements revealed an impaired NO-production, whereas
immunohistochemical stainings pointed for an elevated expres-
sion of VCAM-1, elevated expression of vWF and decreased
expression of the vasoprotective thrombomodulin. Since an up-
or downregulation of these parameters is associated with
endothelial dysfunction,30–32 the presented results confirm the
presence of endothelial dysfunction in the ApoE/LDLR−/−
mice. Based on these findings, we postulate that the increased
intracellular lipid content of the ApoE/LDLR−/− endothelium
contributes to a reduced NO bioavailability and can thus be
regarded as a marker for endothelial dysfunction.
Besides alterations within the biochemical composition, we
could show that the “stiffness” as well as the “Young's Modulus”
of the aortic endothelium in ApoE/LDLR−/− mice is increased
compared to WT animals. In this context “stiffness” is a
parameter which is determined without any underlying hypo-
thetical model and is dependent on the size and shape of the
indenting probe. Hence, to overcome material-dependent
variations, the present study was performed with solely two
cantilevers, both exhibiting identical properties. In addition,
information about the elasticity (i.e. Young's Modulus) of the
same FDC is presented, which considers differences in probe
geometry based on a hypothetical model.23 It should be
mentioned that the mechanical properties vary significantly
depending on the cell region where the force curve was acquired.
Especially, in the case of ex vivo endothelial cells embedded in
an ex vivo aortic patch the exact localization of the probed cell
area is hardly possible (Figure S1). To overcome this issue, we
performed the nanoindentation measurements on many different
spots of the sample, i.e. different regions of the cell body (at least
20 different spots per ex vivo patch). In addition, we used
spherical tips with a diameter of 10 μm for the nanoindentation
measurements which reflect rather the mechanical properties of
the whole cell but not a single/local spot.6
Both approaches led to the same result, i.e. an increased
stiffness and elasticity of the ApoE/LDLR−/− endothelial cell
cortex compared to WT, indicating severe functional impairment
of the vascular endothelium. Especially with regard to the
reduced NO-production in the ApoE/LDLR−/− aortas (EPR-
based measurements), the increased stiffness of the ApoE/LDLR
−/− endothelium can be seen as hallmark for endothelial
dysfunction in that stiff cells release less NO than soft cells.7,8
In contrast, it was also reported, that cellular stiffening is caused
by a reduced NO bioavailability.42 These contradictory findings
might be reasoned by different experimental time courses:
Chronic application of the NOS-inhibitor L-NAME (7 days)
affected cellular stiffness,42 whereas acute L-NAME-exposure
(minutes) was without effect.7 Since the ApoE/LDLR−/−mouse
model reflects a naturally occurring chronic reduction of the NO-
bioavailability, it can be speculated that the increased stiffness of
the ApoE/LDLR−/− endothelial cell cortex is not the origin, but
rather the consequence of the reduced NO-bioavailability. This is
in agreement with a clinical study performed by our group:
Classically, functional inhibition of the endothelial sodium
channel (EnNaC) with amiloride results in cortical softening of
endothelial cells.18,19 However, within the clinical trial an
association between an abolished amiloride-induced softening ofhuman ex vivo vessel preparations (non-responder patients) and
the attendance of endothelial dysfunction was found.22 Since the
non-responders and the ApoE/LDLR−/− animals both reflect a
state of endothelial dysfunction and show altered regulation of
the cortical plasticity, we suggest, that the existence of
endothelial dysfunction itself affects the regulation of the cortical
nanomechanics. However, the mechanisms linking reduced NO-
bioavailability to the development of cortical endothelial
stiffness in ApoE/LDLR−/− need to be defined.
Based on the results of this study, the question about a causal
link between increased intracellular lipid contents and the
coexisting increased cortical stiffness arises. As published
elsewhere, exposure of endothelial cells to oxidized low density
lipoprotein (oxLDL) causes an increase in endothelial stiffness.-
43 Furthermore, cholesterol depletion likely stabilizes the
submembranous cytoskeleton, supporting the link between
hypercholesterolemia and cortical stiffening.12,24,44 Consequent-
ly, we postulate the following sequence of events: The
genetically implemented hypercholesterolemia of the ApoE/
LDLR−/− mice15 causes an increased lipid content of the
endothelial plasma membrane. This chronically attenuates eNOS
activity/NO bioavailability6,9,39 and is associated with alter-
ations of the cortical actin network, leading to increased cortical
stiffness42 and a reduced NO release.7 We postulate a self-
perpetuating process of endothelial dysfunction, which is,
besides other mechanisms, triggered by increased intracellular
lipid contents.
Taken together, the experimental approach described here
represents an unprecedented tool to shed light on the complex
mechanisms behind the development of endothelial dysfunction.
The simultaneous combination of Raman microscopy and AFM
on living endothelial cells ex vivo demonstrated a direct link
between the phenotype of endothelial dysfunction, increased
intracellular lipids and elevated cortical stiffness in the ApoE/
LDLR−/− mice.
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